SEO URLwww.firestrike.ai/deals/orna-therapeutics-lilly-acquisition-2026-6
acquisitionAnnounced · Feb 10, 2026BiotechnologySource · Community DiscussionsArticle · Factual
Lilly acquires Orna Therapeutics
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$2.4B
Target
Orna Therapeutics
Cambridge, Massachusetts
Acquirer
Lilly
Full Acquisition
Status
Announced
Lilly agreed to acquire Orna Therapeutics. Reported deal value: $2.4B. Status: Announced. Sector: Biotechnology. Target headquarters context: Cambridge, Massachusetts, United States.
This page summarizes publicly available information about the transaction as of 2026-02-10. Figures and status may change as filings and press coverage update.
John Ondercin February 10, 2026 Eli Lilly and Company stock closed at $1,044.67, down $13.51, or 1. 28 %, at 4:00 p.m. EST, before rebounding 0.46% to $1,049.17 in pre-market trading as of 4:34 a.m. EST
Deal timeline
Announced
Feb 10, 2026 · eand.co
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Biotechnology with a reported deal value of $2.4B. Figures and status may change as sources update.
Sources: eand.co · Primary article · FireStrike proprietary index